Thursday, March 14, 2013

Texas-based Luminex Corporation & Merck Enter Agreement to Develop Companion Diagnostic to Support Investigational BACE Inhibitor Clinical Development Program for Alzheimer’s Disease

Read about how Texas-based Luminex Corporation & Merck Enter Agreement to Develop Companion Diagnostic to Support Investigational BACE Inhibitor Clinical Development Program for Alzheimer’s Disease.

http://bionews-tx.com/news/2013/03/13/texas-based-luminex-corporation-merck-enter-agreement-to-develop-companion-diagnostic-to-support-investigational-bace-inhibitor-clinical-development-program-for-alzheimers-disease/

No comments:

Post a Comment